Healthcare

Silk Laser Australia Limited (ASX:SLA), trading at A$0.90 as at 30 October 2026, is one of Australia's largest aesthetic clinic networks, providing laser hair removal, cosmetic injectables, advanced skin treatments, and body contouring services through a growing portfolio of corporate and franchise clinics that …

EBR Systems Inc (ASX:EBR), trading at A$0.24 as at 30 October 2026, has passed a pivotal commercialisation milestone in the United States after achieving its 100th commercial implant of the WiSE Cardiac Resynchronisation Therapy System – the world's only wireless cardiac pacing device for …

Telix Pharmaceuticals Limited (ASX:TLX, NASDAQ:TLX), trading at A$16.26 as at 30 October 2026, has emerged as one of Australia's most commercially successful biopharmaceutical companies after reporting first-half 2026 group revenue of US$477 million – a 22% increase on the prior year period – and …

Unaudited revenue for the quarter was $3.45m, equal to about 40% of the company's total FY2026 revenue. Exports accounted for about 40% of revenue, compared with 16% in FY2026, and the company said further orders were in hand for December.

The Minder System was originally cleared for adults aged 18 and older. The expanded clearance, based on clinical and technical data showing safety and performance in adolescents, now covers patients aged 12 and older with drug-resistant epilepsy. The announcement headline refers to patients aged …

Lee Health, a US health system delivering more than 8,000 babies each year, began full commercial deployment of HeraMED's Digital Pregnancy Journey on 15 September 2026 after a six-month pilot. The pilot recorded 92% virtual adoption, a 100% likelihood to recommend and a Net …

In Cohort 3 of the Phase 1b azer-cel trial, which combines azer-cel with a BTK inhibitor in patients who progressed on BTKi therapy, 6 of 7 evaluable patients responded as of 19 October 2026. This represents an 86% response rate, including three complete responses …